$ASLE
AerSale Corp

2023 Q2 Form 10-Q Financial Statement

#000155837023008902 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $69.33M $78.27M
YoY Change -50.34% -36.26%
Cost Of Revenue $49.19M $53.88M
YoY Change -41.88% -29.2%
Gross Profit $20.14M $24.39M
YoY Change -63.37% -47.77%
Gross Profit Margin 29.05% 31.16%
Selling, General & Admin $27.10M $25.22M
YoY Change 15.29% 6.13%
% of Gross Profit 134.54% 103.42%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $900.0K $2.469M
YoY Change 80.0% -13.82%
% of Gross Profit 4.47% 10.12%
Operating Expenses $27.10M $25.22M
YoY Change 15.29% 6.13%
Operating Profit -$6.957M -$833.0K
YoY Change -122.1% -103.63%
Interest Expense $381.0K $1.047M
YoY Change -308.2% -636.92%
% of Operating Profit
Other Income/Expense, Net $1.912M $946.0K
YoY Change 45.4% -188.91%
Pretax Income -$5.045M $113.0K
YoY Change -115.38% -99.48%
Income Tax -$2.357M $108.0K
% Of Pretax Income 95.58%
Net Earnings -$2.688M $5.000K
YoY Change -110.16% -99.97%
Net Earnings / Revenue -3.88% 0.01%
Basic Earnings Per Share -$0.05 $0.00
Diluted Earnings Per Share -$0.08 $0.00
COMMON SHARES
Basic Shares Outstanding 51.22M 51.21M
Diluted Shares Outstanding 51.40M 52.96M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.60M $87.70M
YoY Change -82.46% -48.93%
Cash & Equivalents $34.64M $87.70M
Short-Term Investments
Other Short-Term Assets $47.80M $56.05M
YoY Change -51.49% -43.8%
Inventory $300.7M $223.7M
Prepaid Expenses
Receivables $31.89M $36.27M
Other Receivables $0.00 $0.00
Total Short-Term Assets $312.3M $326.4M
YoY Change -8.04% 3.84%
LONG-TERM ASSETS
Property, Plant & Equipment $22.89M $13.48M
YoY Change 127.74% 58.71%
Goodwill $19.86M $19.86M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $116.5M $89.47M
YoY Change 108.44% 36.12%
Total Long-Term Assets $237.6M $210.9M
YoY Change 33.43% 11.82%
TOTAL ASSETS
Total Short-Term Assets $312.3M $326.4M
Total Long-Term Assets $237.6M $210.9M
Total Assets $549.9M $537.3M
YoY Change 6.22% 6.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.09M $35.15M
YoY Change 17.62% 74.28%
Accrued Expenses $5.546M $5.373M
YoY Change -18.64% -21.11%
Deferred Revenue $3.074M $2.698M
YoY Change -57.35% 16.19%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $62.91M $56.92M
YoY Change 25.37% -10.46%
LONG-TERM LIABILITIES
Long-Term Debt $8.600M $0.00
YoY Change
Other Long-Term Liabilities $68.00K $75.00K
YoY Change -96.38% -96.77%
Total Long-Term Liabilities $68.00K $75.00K
YoY Change -96.38% -96.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $62.91M $56.92M
Total Long-Term Liabilities $68.00K $75.00K
Total Liabilities $101.7M $89.68M
YoY Change 77.89% 22.89%
SHAREHOLDERS EQUITY
Retained Earnings $136.2M $138.8M
YoY Change -1.81% 23.74%
Common Stock $5.000K $5.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $448.3M $447.6M
YoY Change
Total Liabilities & Shareholders Equity $549.9M $537.3M
YoY Change 6.22% 6.83%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.688M $5.000K
YoY Change -110.16% -99.97%
Depreciation, Depletion And Amortization $900.0K $2.469M
YoY Change 80.0% -13.82%
Cash From Operating Activities -$66.76M -$62.44M
YoY Change 3520.39% -245.05%
INVESTING ACTIVITIES
Capital Expenditures $3.330M $1.481M
YoY Change -258.27% -9.53%
Acquisitions
YoY Change
Other Investing Activities $8.200M $4.500M
YoY Change -71.96%
Cash From Investing Activities $4.870M $3.019M
YoY Change -82.06% -284.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.840M -70.00K
YoY Change 3918.18% -156.0%
NET CHANGE
Cash From Operating Activities -66.76M -62.44M
Cash From Investing Activities 4.870M 3.019M
Cash From Financing Activities 8.840M -70.00K
Net Change In Cash -53.05M -59.49M
YoY Change -307.91% -243.23%
FREE CASH FLOW
Cash From Operating Activities -$66.76M -$62.44M
Capital Expenditures $3.330M $1.481M
Free Cash Flow -$70.09M -$63.92M
YoY Change -27057.69% -254.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001754170
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51189461
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51221386
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51189461
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51221386
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38801
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
AerSale Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3976002
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
255 Alhambra Circle, Suite 435
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Coral Gables
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33134
CY2023Q1 dei City Area Code
CityAreaCode
305
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
764-3200
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
ASLE
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51221386
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87695000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147188000
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
1074000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
1074000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36269000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28273000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
277000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
141000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
141000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171724000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-100000
CY2023Q1 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
146408000
CY2022Q4 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
117488000
CY2023Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
29008000
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
27585000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27040000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13022000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
326420000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
333556000
CY2023Q1 asle Aircraft Airframes Engines And Parts Net
AircraftAirframesEnginesAndPartsNet
33555000
CY2022Q4 asle Aircraft Airframes Engines And Parts Net
AircraftAirframesEnginesAndPartsNet
31288000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13481000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12638000
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
77259000
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
66042000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11215000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11287000
CY2023Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
432000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
544000
CY2023Q1 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
560000
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
628000
CY2023Q1 us-gaap Goodwill
Goodwill
19860000
CY2022Q4 us-gaap Goodwill
Goodwill
19860000
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
23587000
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
24112000
CY2023Q1 us-gaap Assets
Assets
537321000
CY2022Q4 us-gaap Assets
Assets
531579000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
35148000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21131000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5373000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8843000
CY2023Q1 asle Lease And Customer Purchase Deposits Current
LeaseAndCustomerPurchaseDepositsCurrent
9100000
CY2022Q4 asle Lease And Customer Purchase Deposits Current
LeaseAndCustomerPurchaseDepositsCurrent
17085000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2698000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1355000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
56919000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52840000
CY2023Q1 us-gaap Lease Deposit Liability
LeaseDepositLiability
152000
CY2022Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
152000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
75000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
668000
CY2023Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
4990000
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
4656000
CY2023Q1 us-gaap Liabilities
Liabilities
89675000
CY2022Q4 us-gaap Liabilities
Liabilities
86599000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51221386
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51189461
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
5000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
308802000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
306141000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
138839000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
138834000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
447646000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
444980000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
537321000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
531579000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78271000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
122806000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
53880000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
76103000
CY2023Q1 us-gaap Gross Profit
GrossProfit
24391000
CY2022Q1 us-gaap Gross Profit
GrossProfit
46703000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25224000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23766000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-833000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
22937000
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1047000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-195000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
233000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
365000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
334000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1234000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
946000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1064000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
113000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21873000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
108000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4647000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17226000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
444980000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2731000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
70000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
447646000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408879000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3755000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
125000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17226000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
429985000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
5000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
17226000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2469000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2865000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
39000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
112000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
773000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
-50000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-424000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
72000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-775000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
334000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1234000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2731000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3755000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7996000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5527000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48983000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-28174000
CY2023Q1 asle Increase Decrease In Deposits Prepaid Expenses And Other Current Assets
IncreaseDecreaseInDepositsPrepaidExpensesAndOtherCurrentAssets
14019000
CY2022Q1 asle Increase Decrease In Deposits Prepaid Expenses And Other Current Assets
IncreaseDecreaseInDepositsPrepaidExpensesAndOtherCurrentAssets
484000
CY2023Q1 asle Increase Decrease In Deferred Customer Incentives And Other Assets
IncreaseDecreaseInDeferredCustomerIncentivesAndOtherAssets
-68000
CY2022Q1 asle Increase Decrease In Deferred Customer Incentives And Other Assets
IncreaseDecreaseInDeferredCustomerIncentivesAndOtherAssets
-123000
CY2023Q1 us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
1423000
CY2022Q1 us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
1941000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14018000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
201000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4975000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3396000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1611000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1343000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-538000
CY2023Q1 asle Increase Decrease In Lessee And Customer Purchase Deposits
IncreaseDecreaseInLesseeAndCustomerPurchaseDeposits
-7985000
CY2022Q1 asle Increase Decrease In Lessee And Customer Purchase Deposits
IncreaseDecreaseInLesseeAndCustomerPurchaseDeposits
-3184000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-593000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1083000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62442000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43048000
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4500000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1481000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1637000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3019000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1637000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-70000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
125000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-59493000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
41536000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147188000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130188000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87695000
CY2022Q1 asle Weighted Average Number Of Shares Assumed Exercise Of Public Warrants
WeightedAverageNumberOfSharesAssumedExerciseOfPublicWarrants
481
CY2022Q4 us-gaap Other Inventory
OtherInventory
73827000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
20202000
CY2022Q1 asle Number Of Leases Terminated Due To Imposition Of Restrictions
NumberOfLeasesTerminatedDueToImpositionOfRestrictions
3
CY2022Q1 asle Number Of Aircrafts Repossessed Due To Imposition Of Restrictions
NumberOfAircraftsRepossessedDueToImpositionOfRestrictions
2
CY2022Q1 asle Number Of Engines To Be Repossessed Due To Imposition Of Restrictions
NumberOfEnginesToBeRepossessedDueToImpositionOfRestrictions
1
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
11659000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7277000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
4382000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1400000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1100000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78271000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
122806000
CY2023Q1 us-gaap Other Inventory
OtherInventory
68792000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
16659000
CY2023Q1 asle Inventory Whole Assets
InventoryWholeAssets
134673000
CY2022Q4 asle Inventory Whole Assets
InventoryWholeAssets
93044000
CY2023Q1 us-gaap Inventory Net
InventoryNet
223667000
CY2022Q4 us-gaap Inventory Net
InventoryNet
183530000
CY2023Q1 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
146408000
CY2022Q4 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
117488000
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
77259000
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
66042000
CY2022Q1 us-gaap Inventory Recall Expense
InventoryRecallExpense
0
CY2023Q1 us-gaap Inventory Recall Expense
InventoryRecallExpense
0
CY2023Q1 asle Indefinite Lived Intangible Assets Net Including Goodwill
IndefiniteLivedIntangibleAssetsNetIncludingGoodwill
30190000
CY2022Q4 asle Indefinite Lived Intangible Assets Net Including Goodwill
IndefiniteLivedIntangibleAssetsNetIncludingGoodwill
30190000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13257000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13782000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7700000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7200000
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
5998000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36230000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34473000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22749000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21835000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13481000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12638000
CY2023Q1 us-gaap Depreciation
Depreciation
900000
CY2022Q1 us-gaap Depreciation
Depreciation
500000
CY2023Q1 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
78705000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
83902000
CY2023Q1 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
45150000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
52614000
CY2023Q1 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
33555000
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
31288000
CY2023Q1 asle Depreciation Property Plant And Equipment Excluding Underlying Asset Under Operating Lease
DepreciationPropertyPlantAndEquipmentExcludingUnderlyingAssetUnderOperatingLease
1100000
CY2022Q1 asle Depreciation Property Plant And Equipment Excluding Underlying Asset Under Operating Lease
DepreciationPropertyPlantAndEquipmentExcludingUnderlyingAssetUnderOperatingLease
1900000
CY2023Q1 us-gaap Operating Leases Income Statement Contingent Revenue
OperatingLeasesIncomeStatementContingentRevenue
3100000
CY2022Q1 us-gaap Operating Leases Income Statement Contingent Revenue
OperatingLeasesIncomeStatementContingentRevenue
3500000
CY2023Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3Y
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Receivable Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear
4372000
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
1483000
CY2023Q1 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
143000
CY2023Q1 asle Weighted Average Number Of Assumed Stock Settled Restricted Stock Units
WeightedAverageNumberOfAssumedStockSettledRestrictedStockUnits
1745293
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2286000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
6040000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1005000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
716000
CY2023Q1 asle Accrued Commission Fee Current
AccruedCommissionFeeCurrent
208000
CY2022Q4 asle Accrued Commission Fee Current
AccruedCommissionFeeCurrent
251000
CY2023Q1 asle Accrued Expenses For Federal State And Local Taxes Payable
AccruedExpensesForFederalStateAndLocalTaxesPayable
183000
CY2022Q4 asle Accrued Expenses For Federal State And Local Taxes Payable
AccruedExpensesForFederalStateAndLocalTaxesPayable
142000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1691000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1694000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5373000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8843000
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
623834
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
623834
CY2022Q4 us-gaap Share Price
SharePrice
18.5306
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
300000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1200000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17226000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51206226
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51686583
CY2022Q1 asle Weighted Average Number Of Assumed Stock Settled Restricted Stock Units
WeightedAverageNumberOfAssumedStockSettledRestrictedStockUnits
1818745
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51221386
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51189461
CY2023Q1 asle Weighted Average Number Of Shares Assumed Settled Employee Awards
WeightedAverageNumberOfSharesAssumedSettledEmployeeAwards
7036
CY2022Q1 asle Weighted Average Number Of Shares Assumed Settled Employee Awards
WeightedAverageNumberOfSharesAssumedSettledEmployeeAwards
4703
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52958555
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53510512
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q1 us-gaap Revenues
Revenues
78271000
CY2022Q1 us-gaap Revenues
Revenues
122806000
CY2023Q1 us-gaap Gross Profit
GrossProfit
24391000
CY2022Q1 us-gaap Gross Profit
GrossProfit
46703000
CY2023Q1 us-gaap Assets
Assets
537321000
CY2022Q1 us-gaap Assets
Assets
531579000
CY2023Q1 us-gaap Gross Profit
GrossProfit
24391000
CY2022Q1 us-gaap Gross Profit
GrossProfit
46703000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25224000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23766000
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1047000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-195000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
233000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
365000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
334000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1234000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
113000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21873000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2022Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
11988

Files In Submission

Name View Source Status
asle-20230331_lab.xml Edgar Link unprocessable
0001558370-23-008902-index-headers.html Edgar Link pending
0001558370-23-008902-index.html Edgar Link pending
0001558370-23-008902.txt Edgar Link pending
0001558370-23-008902-xbrl.zip Edgar Link pending
asle-20230331.xsd Edgar Link pending
asle-20230331x10q.htm Edgar Link pending
asle-20230331xex31d1.htm Edgar Link pending
asle-20230331xex31d2.htm Edgar Link pending
asle-20230331xex32d1.htm Edgar Link pending
asle-20230331xex32d2.htm Edgar Link pending
asle-20230331_cal.xml Edgar Link unprocessable
asle-20230331_def.xml Edgar Link unprocessable
asle-20230331x10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
asle-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending